Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (11)
2023
-
Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study
The Journal of clinical psychiatry, Vol. 84, Núm. 2
-
Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance
JHEP Reports, Vol. 5, Núm. 8
2022
-
The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis
Journal of Psychiatric Research, Vol. 155, pp. 171-179
2021
-
Regulation of the voltage-dependent sodium channel NaV1.1 by AKT1
Neuropharmacology, Vol. 197
-
Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges
Frontiers in Cellular Neuroscience, Vol. 15
2020
-
Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-30
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
2012
-
Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation
Neuropharmacology, Vol. 62, Núm. 2, pp. 1082-1090
2011
-
Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFκB and iNOS
Neurochemistry International, Vol. 58, Núm. 6, pp. 676-683
-
Pharmacological targeting of the transcription factor NRf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism
Antioxidants and Redox Signaling, Vol. 14, Núm. 12, pp. 2347-2360